Alfred E. Mann Foundation sells insulin infusion pump IP to Medtronic

The Alfred E. Mann Foundation for Scientific Research (AMF) today announced the sale of intellectual property to Medtronic (NYSE:MDT).

As part of the transaction of IP related to implanted infusion pumps, AMF will work with Medtronic to develop the technology into a next-generation implantable insulin pump for people living with hard-to-treat type 1 diabetes in Europe.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0